Showing results (91-100 of 139) with videos related to

Sort By:
Pageof 14
Thorax|June 30, 2004
Effect of comorbidity on the treatment and prognosis of elderly patients with non-small cell lung cancerM L G Janssen-Heijnen, S Smulders, V E P P Lemmens, et al.
Breast Cancer Research and Treatment|June 3, 2008
Screening caused rising incidence rates of ductal carcinoma in situ of the breastL N van Steenbergen, A C Voogd, J A Roukema, et al.
European Journal of Cancer Care|December 23, 2011
Predicting the need for end-of-life care for elderly cancer patients: findings from a Dutch regional cancer registry databaseT E Olden, J M G A Schols, J P H Hamers, et al.
British Journal of Cancer|May 27, 2004
Comorbidity has negligible impact on treatment and complications but influences survival in breast cancer patientsS Houterman, M L G Janssen-Heijnen, C D G W Verheij, et al.
British Journal of Cancer|February 24, 2006
The association between antihypertensive drugs and gliomaM P W A Houben, J W W Coebergh, R M C Herings, et al.
European Journal of Cancer (Oxford, England : 1990)|March 15, 2005
Less extensive treatment and inferior prognosis for breast cancer patient with comorbidity: a population-based studyW J Louwman, M L G Janssen-Heijnen, S Houterman, et al.
Breast (Edinburgh, Scotland)|December 3, 2013
Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern NetherlandsL N van Steenbergen, A C Voogd, J A Roukema, et al.
The British Journal of Surgery|November 8, 2012
Impact of age and co-morbidity on surgical resection rate and survival in patients with oesophageal and gastric cancerL B Koppert, V E P P Lemmens, J W W Coebergh, et al.
European Journal of Gastroenterology & Hepatology|June 18, 2004
Comparison of comorbidity prevalence in oesophageal and gastric carcinoma patients: a population-based studyL B Koppert, M L G Janssen-Heijnen, M W J Louwman, et al.
European Journal of Cancer (Oxford, England : 1990)|October 13, 2006
Transforming-growth factor beta1 Leu10Pro polymorphism and breast cancer morbidityA M González-Zuloeta Ladd, A Arias-Vásquez, C Siemes, et al.
Pageof 14